PANAGORA ASSET MANAGEMENT INC

Position in FHTX — Foghorn Therapeutics Inc.

CIK 883677 Boston, MA

Position in FHTX

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$855,981

+$305,980 QoQ

Shares Held

175,406

+52.4% QoQ

Ownership

0.295%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#23

of 102 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 13% Shared 0% None 87%

Healthcare · as of Jun 30, 2026

PANAGORA ASSET MANAGEMENT INC holds $624,607,308 across 78 Biotechnology names. FHTX ranks #50 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	175,291	$109,300,950
2	INCY	Incyte Corp	881,889	$99,970,937
3	XENE	Xenon Pharmaceuticals Inc.	664,031	$40,080,911
4	MIRM	Mirum Pharmaceuticals, Inc.	337,461	$39,506,559
5	TVTX	Travere Therapeutics, Inc.	490,724	$27,878,030
6	JAZZ	Jazz Pharmaceuticals plc	104,935	$25,286,186
7	RLAY	Relay Therapeutics, Inc.	1,291,182	$24,158,015
8	CLDX	Celldex Therapeutics, Inc.	572,538	$21,304,138

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$855,981	175,406	+52.4%	Shares	Sole	2026-08-06
2026-03-31	$550,001	115,063	+28.9%	Shares	Sole	2026-05-14
2025-12-31	$482,193	89,295	+36.7%	Shares	Sole	2026-02-13
2025-09-30	$319,497	65,337	0.0%	Shares	Sole	2025-11-13
2025-06-30	$307,083	65,337	+20.2%	Shares	Sole	2025-08-13
2025-03-31	$198,322	54,335	-1.5%	Shares	Sole	2025-05-15
2024-12-31	$260,326	55,154	+40.6%	Shares	Sole	2025-02-13
2024-09-30	$365,333	39,241	-60.2%	Shares	Sole	2024-11-13
2024-06-30	$566,530	98,527	-1.8%	Shares	Sole	2024-07-29
2024-03-31	$673,046	100,305	+3.4%	Shares	Sole	2024-05-07
2023-12-31	$625,759	97,017	+180.6%	Shares	Sole	2024-02-08
2023-09-30	$172,880	34,576	—	Shares	Sole	2023-10-31
No filing history on record for this holder in this stock.